Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor-Reference-Cited by-同舟云学术

Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor

Published:2017-06-28 Issue:40 Volume:8 Page:67754-67768
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Montano Ryan¹,Khan Nadeem²³,Hou Huagang²³,Seigne John⁴³,Ernstoff Marc S.⁴³⁵,Lewis Lionel D.⁴³,Eastman Alan¹³

Affiliation:

1. Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA

2. Department of Radiology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA

3. Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA

4. Department of Medicine, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA

5. Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 3D Pancreatic Cancer Model with Integrated Optical Sensors for Noninvasive Metabolism Monitoring and Drug Screening;Advanced Healthcare Materials;2024-07-08

2. Targeting ATR in patients with cancer;Nature Reviews Clinical Oncology;2024-02-20

3. Efficacy and safety of short-term intravesical gemcitabine vs. long-term intravesical epirubicin in the treatment of moderate to high-risk non-muscle-invasive bladder cancer: a pilot study;Holistic Integrative Oncology;2024-02-20

4. A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma;Clinical Cancer Research;2023-10-11

5. Cancer Biology;Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective;2023-03-05